Related Experiment Video
Updated: Jul 11, 2026

Assessment and Evaluation of the High Risk Neonate: The NICU Network Neurobehavioral Scale
Published on: August 25, 2014
Prenatal low-level lead exposure and developmental delay of infants at age 6 months (Krakow inner city study)
Wieslaw Jedrychowski1, Frederica Perera, Jeffery Jankowski
1Epidemiology and Preventive Medicine, Jagiellonian University, Collegium Medicum, Krakow, Poland. myjedryc@cyf-kr.edu.pl <myjedryc@cyf-kr.edu.pl>
Insights
Prenatal lead exposure in pregnant mothers is linked to lower infant visual recognition memory (VRM) scores. Reducing maternal blood lead levels may prevent developmental delays in infants.
Area of Science:
- Environmental Health
- Neurodevelopmental Pediatrics
- Toxicology
Background:
- Prenatal exposure to environmental toxins, such as lead (Pb), can impact infant neurodevelopment.
- Assessing early cognitive function is crucial for identifying potential developmental risks.
- Visual recognition memory (VRM) is a key indicator of infant cognitive status.
Purpose of the Study:
- To evaluate the neurocognitive status of 6-month-old infants exposed to varying levels of lead in utero.
- To determine the relationship between maternal prenatal lead exposure and infant visual recognition memory (VRM).
Main Methods:
- A cohort of 452 infants born between 33-42 weeks gestation was studied.
- Maternal lead exposure was assessed via cord blood lead levels.
- Infant visual recognition memory (VRM) was measured using the Fagan Test of Infant Intelligence (FTII).
Main Results:
- A significant inverse correlation was found between cord blood lead levels and infant VRM scores (Spearman r = -0.16, p=0.007).
- Infants in the higher lead exposure group (>1.67 microg/dl) had significantly lower mean Fagan scores (58.4) compared to the lower exposed group (61.0).
- Higher prenatal lead exposure (above 1.67 microg/dl) was associated with a two-fold increased risk of scoring in the high-risk group for developmental delay (OR=2.33).
Conclusions:
- Prenatal lead exposure negatively impacts infant visual recognition memory and is associated with developmental delay risk.
- Reducing maternal blood lead levels below 1.67 microg/dl could prevent approximately 50% of VRM deficits in exposed infants.
- While a screening criterion based on cord blood lead levels shows promise, further refinement is needed due to its low positive predictive value.
Abstract:
The purpose of the study was to assess the neurocognitive status of 6-month-old infants whose mothers were exposed to low but varying amounts of lead during pregnancy. Lead levels in the cord blood were used to assess environmental exposure and the Fagan Test of Infant Intelligence (FTII) assessed visual recognition memory (VRM). The cohort consisted of 452 infants of mothers who gave birth to babies at 33-42 weeks of gestation between January 2001 and March 2003. The overall mean lead level in the cord blood was 1.42 microg/dl (95% CI: 1.35-1.48). We found that VRM scores in 6 month olds were inversely related to lead cord blood levels (Spearman correlation coefficient -0.16, p=0.007). The infants scored lower by 1.5 points with an increase by one unit (1 microg/dl) of lead concentration in cord blood. In the lower exposed infants (1.67 microg/dl) the mean Fagan score was 61.0 (95% CI: 60.3-61.7) and that in the higher exposed group (>1.67 microg/dl) was 58.4 (95% CI: 57.3-59.7). The difference of 2.5 points was significant at the p=0.0005 level. The estimated risk of scoring the high-risk group of developmental delay (FTII classification 3) due to higher lead blood levels was two-fold greater (OR=2.33, 95% CI: 1.32-4.11) than for lower lead blood levels after adjusting for potential confounders (gestational age, gender of the child and maternal education). As the risk of the deficit in VRM score (Fagan group 3) in exposed infants attributable to Pb prenatal exposure was about 50%, a large portion of cases with developmental delay could be prevented by reducing maternal blood lead level below 1.67 microg/dl. Although the negative predictive value of the chosen screening criterion (above 1.67 microg/dl) was relatively high (89%) its positive predictive value was too low (22%), so that the screening program based on the chosen cord blood lead criterion was recommended.
Related Concept Videos
Environmental Influences on Intelligence
Attention-Deficit/Hyperactivity Disorder
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.

